11-64713324-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_015080.4(NRXN2):​c.376C>G​(p.Leu126Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000027 in 1,371,100 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L126M) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000024 ( 0 hom. )

Consequence

NRXN2
NM_015080.4 missense

Scores

5
10
4

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.56

Publications

1 publications found
Variant links:
Genes affected
NRXN2 (HGNC:8009): (neurexin 2) This gene encodes a member of the neurexin gene family. The products of these genes function as cell adhesion molecules and receptors in the vertebrate nervous system. These genes utilize two promoters. The majority of transcripts are produced from the upstream promoter and encode alpha-neurexin isoforms while a smaller number of transcripts are produced from the downstream promoter and encode beta-neuresin isoforms. The alpha-neurexins contain epidermal growth factor-like (EGF-like) sequences and laminin G domains, and have been shown to interact with neurexophilins. The beta-neurexins lack EGF-like sequences and contain fewer laminin G domains than alpha-neurexins. Alternative splicing and the use of alternative promoters may generate thousands of transcript variants (PMID: 12036300, PMID: 11944992).[provided by RefSeq, Jun 2010]
NRXN2 Gene-Disease associations (from GenCC):
  • autism
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Ambry Genetics
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NRXN2NM_015080.4 linkc.376C>G p.Leu126Val missense_variant Exon 2 of 23 ENST00000265459.11 NP_055895.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NRXN2ENST00000265459.11 linkc.376C>G p.Leu126Val missense_variant Exon 2 of 23 5 NM_015080.4 ENSP00000265459.5
NRXN2ENST00000704782.1 linkc.376C>G p.Leu126Val missense_variant Exon 1 of 22 ENSP00000516031.1
NRXN2ENST00000704781.1 linkc.376C>G p.Leu126Val missense_variant Exon 1 of 22 ENSP00000516029.1

Frequencies

GnomAD3 genomes
AF:
0.0000527
AC:
8
AN:
151662
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000965
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000479
GnomAD4 exome
AF:
0.0000238
AC:
29
AN:
1219330
Hom.:
0
Cov.:
34
AF XY:
0.0000235
AC XY:
14
AN XY:
595274
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24056
American (AMR)
AF:
0.00
AC:
0
AN:
11438
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17290
East Asian (EAS)
AF:
0.000223
AC:
6
AN:
26938
South Asian (SAS)
AF:
0.000128
AC:
7
AN:
54490
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
29468
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3540
European-Non Finnish (NFE)
AF:
0.00000200
AC:
2
AN:
1002192
Other (OTH)
AF:
0.000280
AC:
14
AN:
49918
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000527
AC:
8
AN:
151770
Hom.:
0
Cov.:
34
AF XY:
0.0000943
AC XY:
7
AN XY:
74196
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41512
American (AMR)
AF:
0.00
AC:
0
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000968
AC:
5
AN:
5164
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10362
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67874
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 20, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.376C>G (p.L126V) alteration is located in exon 2 (coding exon 1) of the NRXN2 gene. This alteration results from a C to G substitution at nucleotide position 376, causing the leucine (L) at amino acid position 126 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Uncertain
-0.080
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.045
T;.;T;.
Eigen
Uncertain
0.56
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.93
.;D;D;D
M_CAP
Pathogenic
0.75
D
MetaRNN
Uncertain
0.55
D;D;D;D
MetaSVM
Uncertain
0.79
D
MutationAssessor
Pathogenic
3.0
M;M;M;.
PhyloP100
2.6
PrimateAI
Pathogenic
0.96
D
PROVEAN
Benign
-2.1
N;N;N;N
REVEL
Pathogenic
0.75
Sift
Uncertain
0.0010
D;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D
Polyphen
1.0
D;D;D;.
Vest4
0.19
MutPred
0.71
Gain of MoRF binding (P = 0.0933);Gain of MoRF binding (P = 0.0933);Gain of MoRF binding (P = 0.0933);Gain of MoRF binding (P = 0.0933);
MVP
0.83
MPC
0.62
ClinPred
0.92
D
GERP RS
3.5
PromoterAI
-0.0022
Neutral
Varity_R
0.62
gMVP
0.57
Mutation Taster
=59/41
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370521049; hg19: chr11-64480796; API